The p38α pharmacological inhibitior has also been shown to be able to combine with cisplatin to decrease colony formation and viability of cancer cells and strongly increase Bax-dependent apoptotic cell death by activating FOXO3 in colorectal cancer (CRC) cells[32]. The gene discussed is FOXO3; the disease is cancer.